The India advantage India is emerging as a preferred hub for both pharma and medical devices, offering a strategic advantage in the GLP-1 race
For example, IF is generally not recommended for individuals with eating disorders, who often exhibit significant disruptions in eating behaviors and require individualized, structured therapeutic approaches
To study the role of GLP-1R in microglial inflammation, BV-2 cells were preincubated with the selective GLP-1R agonist liraglutide (100 nM, Selleck, TX, USA) and the antagonist exendin(939) (200 nM, MCE, USA) for 24 h, followed by LPS (1 g/ml, SigmaAldrich, MO, USA) stimulation for 24 h
The co-administration of drugs reduces mortality but also introduces more drugdrug interactions and increases the risk of developing immune reconstitution inflammatory syndrome (IRIS) [66]
BMC Public Health 26 , 915 (2026)